A New Chapter in Comprehensive Management of Renal Cell Carcinoma | Professors Youyan Guan and Xiongjun Ye Provide In-Depth Insights

A New Chapter in Comprehensive Management of Renal Cell Carcinoma | Professors Youyan Guan and Xiongjun Ye Provide In-Depth Insights

2025.11.03
On August 22–23, 2025, the 2025 Pujiang Uro-Oncology Conference was held in Shanghai, bringing together leading experts to discuss advances in urologic oncology. This article is based on the pre-conference session presented by Professor Youyan Guan (Cancer Hospital, Chinese Academy of Medical Sciences) and Professor Xiongjun Ye, titled “Comprehensive Management of Renal Cancer Patients.” Their lecture systematically reviewed the evolution of treatment concepts, perioperative and advanced-stage strategies, and the construction of comprehensive management systems, aiming to provide clinical and research colleagues with valuable reference and guidance.
Transformative Advances in mHSPC Treatment Strategies

Transformative Advances in mHSPC Treatment Strategies

2025.11.03
Editor’s Note: On August 22–23, 2025, the highly anticipated 2025 Pujiang Uro-Oncology Conference was held in Shanghai, gathering leading experts in urologic oncology from across China and abroad. Among the key topics was the optimization of treatment strategies for metastatic hormone-sensitive prostate cancer (mHSPC). Professor Xinan Sheng from Peking University Cancer Hospital delivered an insightful lecture titled “The Combination Revolution in mHSPC — Multi-Strategy Optimization of Patient Management.” His talk provided a systematic review of the current treatment landscape, key challenges, and future directions for mHSPC management.
Good News | Academician Xu Zhang Elected Chair of ARUS, Professor Gang Zhu Elected Secretary-General

Good News | Academician Xu Zhang Elected Chair of ARUS, Professor Gang Zhu Elected Secretary-General

2025.11.03
Recently, the Asian Robotic Urology Section (ARUS), one of the subspecialty committees under the Urological Association of Asia (UAA), held its leadership election and a chair handover ceremony during the UAA Annual Meeting. China’s Academician Xu Zhang has been officially elected as Chair of ARUS, and Professor Gang Zhu has been appointed Secretary-General.
Professor Fang Liu: Unveiling the Application and Future Prospects of CAR-T Therapy in Acute Myeloid Leukemia丨13th Lu Daopei Hematology Conference

Professor Fang Liu: Unveiling the Application and Future Prospects of CAR-T Therapy in Acute Myeloid Leukemia丨13th Lu Daopei Hematology Conference

2025.11.02
On August 22–23, 2025, the 13th Lu Daopei Hematology Conference was held in Beijing, jointly organized by the Beijing Health Promotion Association and the Guangzhou Kapok Oncology and Rare Disease Foundation, and hosted by the Beijing Lu Daopei Hematology Institute. The conference gathered world-leading hematology experts and focused on hematopoietic stem cell transplantation, cellular therapy, and precision treatment of hematologic malignancies. With over a thousand participants, the meeting provided a high-level and in-depth academic exchange. During the conference, Professor Fang Liu from Shanghai Xindaobei Hematology Hospital delivered a presentation on the latest clinical advances of CAR-T therapy in acute myeloid leukemia (AML). Oncology Frontier – Hematology News invited Professor Liu to elaborate on the core clinical issues, offering important insights to guide optimized management strategies.